Chemocentryx (CCXI) Narrows Q3 Loss to 28c/Share

Chemocentryx (NASDAQ: CCXI) reported Q3 EPS of ($0.28), versus ($2.06) reported last year. Revenue for the quarter came in at $1.13 million, versus $1.44 million reported last year.

For earnings history and earnings-related data on Chemocentryx (CCXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Employers Holdings (EIG) Misses Q1 EPS by 2c
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance